AzTrials
AzTrials

Refractive ErrorsNCT04161326

Environmental Health and Myopia Prevention and Control

An observational study of Refractive Errors and Myopia (Disorder), run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Myopia is one of the major causes of low visual acuity during childhood. It is generally more prevalent in urban areas than in rural areas. Current evidence does not address our understanding of the myopia incidence and development and associated risk geographic factors, such as green spaces. Read more about this study

Who is it for?
Ages 6 to 9 yearsHealthy volunteers can take part
Conditions the study is for
Refractive Errors, Myopia (Disorder)
How many people
100,000 participants
Where
1 siteChina
Study dates
1 Jan 2016to 30 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: A prospective longitudinal cohort study of schoolchildren who studied in the 1st to 4th grades was performed.

Who may be able to join

  • schoolchildren in the 1st to 4th grades

Who cannot join

  • schoolchildren unwilling to participate

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510000

    Yahan Yang, MD., +86-15521013933, yah.yang@hotmail.com

    Recruiting

Other trials in China

About this study

Official title: Environmental Health and Myopia Prevention and Control: A Longitudinal Study in China

Myopia is one of the major causes of low visual acuity during childhood. It is generally more prevalent in urban areas than in rural areas. Current evidence does not address our understanding of the myopia incidence and development and associated risk geographic factors, such as green spaces. Therefore, our study aimed to evaluate the association between geographic factors and myopia base on a population-based large-scaled cohort design.

Medical subject headings
Refractive Errors, Myopia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the changes of spherical equivalent refractive (RSE)

    A multi-linear regression was used.

    Measured: up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Nov 2019
  2. Study start1 Jan 2016
  3. Primary completion30 Dec 2019
  4. Study completion30 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04161326
Sponsor's protocol ID
CCPMOH2016-China-0304
Status last verified
Feb 2020
First submitted
11 Nov 2019
Last updated
25 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Refractive Errors and Myopia (Disorder), run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yahan Yang, M.D (+8615521013933, yah.yang39@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the changes of spherical equivalent refractive (RSE) (time frame: up to 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in